Operating income increased 198.7%
Operating income changed +198.7% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income changed +198.7% from the comparable as-filed period.
Operating margin changed +906 basis points from the comparable as-filed period.
Net income changed +173.1% from the comparable as-filed period.
Working capital changed +247.6% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Shares outstanding changed -8.0% from the comparable as-filed period. The change ranks at the 88th percentile of 8 prior comparable changes.
Cash & equivalents changed +58.8% from the comparable as-filed period.
Short-term borrowings changed -100.0% from the comparable as-filed period.
Revenue changed +7.0% from the comparable as-filed period.
Noncurrent long-term debt changed +20.7% from the comparable as-filed period.
Working capital / assets changed +220 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Stock-based compensation changed +36.1% from the comparable as-filed period.
Total assets changed +4.8% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Capex / revenue changed -33 basis points from the comparable as-filed period.
Selling, general & administrative changed +5.6% from the comparable as-filed period.
Current liabilities changed -5.3% from the comparable as-filed period.
Current ratio changed +9.4% from the comparable as-filed period.
SBC / revenue changed +9 basis points from the comparable as-filed period.
Current assets changed +3.6% from the comparable as-filed period.
Capital expenditure changed +0.5% from the comparable as-filed period.
Debt changed -100.0% from the comparable as-filed period. The change ranks at the 85th percentile of 110 prior comparable changes.
Cash & equivalents changed -0.0% from the comparable as-filed period. The change ranks at the 0th percentile of 239 prior comparable changes.
Capital expenditure changed +1.5% from the comparable as-filed period. The change ranks at the 4th percentile of 76 prior comparable changes.
Capex / revenue changed -29 basis points from the comparable as-filed period. The change ranks at the 27th percentile of 33 prior comparable changes.
Selling, general & administrative changed +9.0% from the comparable as-filed period. The change ranks at the 48th percentile of 132 prior comparable changes.
Revenue changed +7.2% from the comparable as-filed period. The change ranks at the 53th percentile of 59 prior comparable changes.
Operating margin changed +124 basis points from the comparable as-filed period. The change ranks at the 36th percentile of 59 prior comparable changes.
Stock-based compensation changed +22.7% from the comparable as-filed period. The change ranks at the 70th percentile of 100 prior comparable changes.
Operating income changed +23.2% from the comparable as-filed period. The change ranks at the 60th percentile of 136 prior comparable changes.
Net income changed +1.1% from the comparable as-filed period. The change ranks at the 6th percentile of 136 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.